LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,400 | -24.4% | 10,000 | 0.0% | 0.00% | – |
Q4 2022 | $4,500 | -59.1% | 10,000 | -18.0% | 0.00% | -100.0% |
Q3 2022 | $11,000 | -21.4% | 12,200 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $14,000 | -33.3% | 12,200 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $21,000 | -47.5% | 12,200 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $40,000 | -18.4% | 12,200 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $49,000 | – | 12,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |